文献速递血管炎

ERAP1/ERAP2与HLA-B*52:01在Takayasu动脉炎中的遗传交互作用探索

Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究利用大型多祖先GWAS数据,分析ERAP1/ERAP2多态性与Takayasu动脉炎的遗传关联及其与HLA-B*52:01的交互作用。分析提示ERAP1或ERAP2与HLA-B*52:01在Takayasu动脉炎中无显著遗传交互作用,且ERAP1/ERAP2与Takayasu动脉炎无显著关联,包括显性或隐性模型及按HLA-B*52:01状态分层后。结果提示Takayasu动脉炎的遗传特征不同于其他MHC-I-opathies,支持其作为该组免疫介导疾病中的独特亚型。

要点

  • ERAP1/ERAP2与HLA-B*52:01在Takayasu动脉炎中未见显著遗传交互作用。
  • ERAP1/ERAP2与Takayasu动脉炎的关联分析(含显性/隐性模型及HLA-B*52:01分层)均无显著关联。
  • 结果提示Takayasu动脉炎遗传特征不同于其他MHC-I-opathies,支持其为独特亚型。

核心结论

  • ERAP1或ERAP2与HLA-B*52:01在Takayasu动脉炎中无显著遗传交互作用,与其他MHC-I-opathies中所见相反。
  • ERAP1/ERAP2与Takayasu动脉炎无显著关联,包括显性/隐性模型及按HLA-B*52:01状态分层分析。
  • Takayasu动脉炎的遗传特征不同于其他MHC-I-opathies,支持其作为该组免疫介导疾病中的独特亚型。
  • 这些发现具有假设生成性,需要在更大队列中验证。

研究设计与样本

  • 利用大型多祖先GWAS数据,分析ERAP1和ERAP2多态性与Takayasu动脉炎的遗传关联。
  • 进行ERAP1/ERAP2多态性与HLA-B*52:01的遗传交互分析,并进行跨人群meta分析。
  • 在HLA-B*52:01阳性个体中限制性进行ERAP1/ERAP2多态性的遗传关联检验。

主要发现

  • 分析提示ERAP1或ERAP2与HLA-B*52:01在Takayasu动脉炎中无显著遗传交互作用。
  • 未检测到ERAP1/ERAP2与Takayasu动脉炎之间的显著关联,包括显性/隐性模型及按HLA-B*52:01状态分层后。

局限性

  • 这些发现具有假设生成性,需要在更大队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Takayasu arteritis is a rare vasculitis characterized by inflammation of large arteries. Given the robust genetic association with HLA-B*52:01, it was recently proposed to classify Takayasu arteritis within the spectrum of MHC-I-opathies. Although genetic associations in ERAP1 and ERAP2 have been described in several MHC-I-opathies, their role in Takayasu arteritis remains unclear. This study investigated the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis. METHODS: Using data from a large multi-ancestral GWAS, we examined the genetic association between ERAP1 and ERAP2 polymorphisms with Takayasu arteritis. Next, we conducted genetic interaction analyses between ERAP1/ERAP2 polymorphisms and HLA-B*52:01, followed by a meta-analysis across populations. In addition, we conducted a genetic association test for ERAP1/ERAP2 polymorphisms restricted to HLA-B*52:01-positive individuals. RESULTS: Our analyses suggested no significant genetic interactions between ERAP1 or ERAP2 and HLA-B*52:01 in Takayasu arteritis, which contrasts with the findings observed in other MHC-I-opathies. In addition, no significant associations between ERAP1/ERAP2 and Takayasu arteritis were detected, including analyses under dominant or recessive models, or after stratifying by HLA-B*52:01 status. CONCLUSION: These results suggest that the genetic profile of Takayasu arteritis differs from other MHC-I-opathies, supporting its classification as a distinct subtype within this group of immune-mediated diseases. These finding are hypothesis-generating, and validation in larger cohorts is warranted.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Casares-Marfil D, Saruhan-Direskeneli G, Grayson PC, et al. Exploring the genetic interaction between ERAP1/ERAP2 and HLA-B*52:01 in Takayasu arteritis. Rheumatology (Oxford). 2026. PMID: 41100049. doi:10.1093/rheumatology/keaf544

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。